文献速递泌尿系结石

低剂量他达拉非优于坦索罗辛吗?一项针对孤立性上尿路结石体外冲击波碎石术的随机对照试验

Is low-dose tadalafil better than tamsulosin? A randomized controlled trial in shockwave lithotripsy for solitary upper tract calculi.
PubMed 文献 · BJU Int · 2023-05-28

这项三盲、前瞻性、优效性、随机对照、单中心试验纳入250例6-24 mm孤立性肾或输尿管结石患者,1:1随机接受坦索罗辛0.4 mg或他达拉非5 mg每日一次,持续30天或至结石清除。30天结石排出率坦索罗辛组99例(81.1%)vs 他达拉非组98例(80.3%),差异无统计学意义(P=0.874);排出天数几何均值13.59 vs 13.74天(P=0.928)。他达拉非组4例因药物不良反应停药。

要点

  • 30天结石排出率坦索罗辛组81.1% vs 他达拉非组80.3%,差异无统计学意义(P=0.874)。
  • 排出天数几何均值坦索罗辛组13.59天 vs 他达拉非组13.74天,差异无统计学意义(P=0.928)。
  • 他达拉非组4例因药物不良反应停药,原文指出他达拉非耐受性较差。

核心结论

  • 低剂量他达拉非作为体外冲击波碎石术辅助用药,在改善结石排出方面不优于坦索罗辛。
  • 本研究中他达拉非耐受性较差。

研究设计与样本

  • 三盲、前瞻性、优效性、随机对照、单中心试验,共纳入250例孤立性肾或输尿管结石(6-24 mm)患者。
  • 患者按1:1随机接受坦索罗辛0.4 mg或他达拉非5 mg每日一次,持续30天或至结石清除(以较早者为准)。

主要发现

  • 主要结局30天结石排出率:坦索罗辛组99例(81.1%)vs 他达拉非组98例(80.3%),95%CI=0.8%[-9.0, 10.7],P=0.874。
  • 次要结局排出天数几何均值(SD):坦索罗辛组13.59(2.39)天 vs 他达拉非组13.74(2.39)天,P=0.928。
  • 他达拉非组4例因药物不良反应停药。

临床怎么用

  • 原文结论为低剂量他达拉非作为体外冲击波碎石术辅助用药不优于坦索罗辛,且他达拉非耐受性较差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To ascertain whether low-dose tadalafil (5 mg) is more efficient than tamsulosin (0.4 mg) in facilitating calculus expulsion in those receiving extracorporeal shockwave lithotripsy for solitary upper urinary tract calculi. PATIENTS AND METHODS: This was a triple-blinded, prospective, superiority, randomized controlled, single-centre trial. A total of 250 patients with solitary renal or ureteric calculus measuring 6-24 mm were randomized (1:1) to receive either 0.4 mg tamsulosin or 5 mg tadalafil daily for 30 days or until calculus clearance, whichever was earlier. RESULTS: There was no difference in the primary outcome, namely, calculus expulsion rate at 30 days (tamsulosin vs tadalafil, n (%) 99 [81.1%] vs 98 [80.3%] respectively, 95% confidence interval = 0.8% [-9.0, 10.7], P = 0.874). Similarly, a lack of difference was also noted in the secondary outcome, number of days to expulsion (tamsulosin vs tadalafil, geometric mean [SD] 13.59 [2.39] vs 13.74 [2.39] respectively, P = 0.928). Four patients discontinued the drug due to adverse drug reactions in the tadalafil group. CONCLUSIONS: Low-dose tadalafil is not superior to tamsulosin in improving calculus expulsion when used as an adjunct to shockwave lithotripsy. In this study, we also noted that tadalafil was less tolerated.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Sadanala ME, Dangi AD, Rajendran G, et al. Is low-dose tadalafil better than tamsulosin? A randomized controlled trial in shockwave lithotripsy for solitary upper tract calculi. BJU Int. 2023. PMID: 37129977. doi:10.1111/bju.16038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。